Abstract:Conjugation chemistries are a critical technology in nanomedicine, enabling precise functionalization of nanoparticle surfaces (e.g., via attachment of targeting moieties). This work investigates how conjugation chemistry impacts nanoparticle‐induced complement activation. The results demonstrate that modern conjugation chemistries, although bio‐orthogonal, are not innocuous and must be chosen with opsonins like complement in mind. Conjugation chemistries are a major enabling technology for the development of drug delivery systems, from antibody‐drug conjugates to antibody‐targeted lipid nanoparticles inspired by the success of the COVID‐19 vaccine. However, here it is shown that for antibody‐targeted nanoparticles, the most popular conjugation chemistries directly participate in the activation of the complement cascade of plasma proteins. Their activation of complement leads to large changes in the biodistribution of nanoparticles (up to 140‐fold increased uptake into phagocytes of the lungs) and multiple toxicities, including a 50% drop in platelet count. It is founded that the mechanism of complement activation varies dramatically between different conjugation chemistries. Dibenzocyclooctyne, a commonly used click‐chemistry, caused aggregation of conjugated antibodies, but only on the surface of nanoparticles (not in bulk solution). By contrast, thiol‐maleimide chemistry do not activate complement via its effects on antibodies, but rather because free maleimide bonded to albumin in plasma, and clustered albumin is then attacked by complement. Using these mechanistic insights, solutions are engineered that reduced the activation of complement for each class of conjugation chemistry. These results highlight that while conjugation chemistry is essential for the future of nanomedicine, it is not innocuous and must be designed with opsonins like complement in mind.

Single-walled carbon nanotube surface control of complement recognition and activation

Complement Activation by PEGylated Single-Walled Carbon Nanotubes is Independent of C1q and Alternative Pathway Turnover

Interfacing Carbon Nanotubes With Living Cells

Reprogramming Cellular Signaling Machinery Using Surface-Modified Carbon Nanotubes

Size-dependent Impact of CNTs on Dynamic Properties of Calmodulin.

Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins

Role of Surface Charge of Nanoscale Ultrasound Contrast Agents in Complement Activation and Phagocytosis

Formation of Protein Corona on Nanoparticle Affects Different Complement Activation Pathways Mediated by C1q

Carbon Nanotubes: Mechanistic Study on the Reduction of SWCNT‐induced Cytotoxicity by Albumin Coating (Part. Part. Syst. Charact. 12/2014)

Conjugation Chemistry Markedly Impacts Toxicity and Biodistribution of Targeted Nanoparticles, Mediated by Complement Activation

Immuno-Carbon Nanotubes and Recognition of Pathogens

Nanotubes in Biosensing

Preparation of carbon nanotube bioconjugates for biomedical applications

Noncovalent functionalization of carbon nanotubes with lectin for label-free dynamic monitoring of cell-surface glycan expression.

Modulation Of Apoptotic Pathways Of Macrophages By Surface-Functionalized Multi-Walled Carbon Nanotubes

Surface Design of Carbon Nanotubes for Optimizing the Adsorption and Electrochemical Response of Analytes

Non-Covalent Functionalization of Carbon Nanotubes for Electrochemical Biosensor Development

Nanoparticle-Binding Immunoglobulins Predict Variable Complement Responses in Healthy and Diseased Cohorts

Reducing Nanotube Cytotoxicity Using A Nano-Combinatorial Library Approach

Binding of Blood Proteins to Carbon Nanotubes Reduces Cytotoxicity.